Zobrazeno 1 - 9
of 9
pro vyhledávání: '"John Milburn, Jessup"'
Autor:
Timothy Lewis, Cannon, Laura, Knopp, Hongkun, Wang, Tiffani, DeMarco, John Milburn, Jessup, Jamie, Randall, Erica, Kim, Donald L, Trump
Publikováno v:
Current Problems in Cancer. 46:100860
Patient engagement in medical decision-making improves patient related outcomes through compliance and patient satisfaction. The Inova Schar Cancer Institute has a weekly molecular tumor board (MTB) to match comprehensive genomic sequencing results w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4bc41b9998d48e196eafb56c0f560e4
https://doi.org/10.1016/j.currproblcancer.2022.100860
https://doi.org/10.1016/j.currproblcancer.2022.100860
Autor:
Daniel D. Taub, John Milburn Jessup
Publikováno v:
Cancer Research. 80:966-966
Introduction: The purposes of this study were to define the optimal concentration of Oxaliplatin (L-OHP) that induces Immunogenic Cell Death (ICD) in Colorectal Carcinomas (CRC) and whether this can be achieved by such standard first line chemotherap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3bf297aed9063532418f54db3d5c72f
https://doi.org/10.1158/1538-7445.am2020-966
https://doi.org/10.1158/1538-7445.am2020-966
Autor:
John Milburn Jessup, Andrew K. Stewart, Frederick L. Greene, Leonard L. Gunderson, Daniel J. Sargent
Publikováno v:
Journal of Clinical Oncology. 28:256-263
Purpose The sixth edition of the American Joint Committee on Cancer (AJCC) rectal cancer staging subdivided stage II into IIA (T3N0) and IIB (T4N0) and stage III into IIIA (T1-2N1M0), IIIB (T3-4N1M0), and IIIC (anyTN2M0). Subsequent analyses supporte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef42b10631866367f3a84af03abb7a13
https://doi.org/10.1200/jco.2009.23.9194
https://doi.org/10.1200/jco.2009.23.9194
Autor:
Aparna Mani, Janice D. Rone, Anirban Maitra, Bassem R. Haddad, John Milburn Jessup, Sung Eun Kim, Anna T. Riegel, Ralf T. Henke, Anton Wellstein
Publikováno v:
Clinical Cancer Research. 10:6134-6142
Purpose: The nuclear receptor coactivator amplified in breast cancer 1 (AIB1) was found to be amplified and overexpressed in breast and some other epithelial tumors. We have reported that expression of AIB1 is rate limiting for growth factor, as well
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b8cedde92abd990a601eee39e7e9066
https://doi.org/10.1158/1078-0432.ccr-04-0561
https://doi.org/10.1158/1078-0432.ccr-04-0561
Autor:
Adam C. Seegmiller, Maryalice Stetler-Stevenson, Gerard Lozanski, Michael J. Borowitz, Aaron C. Shaver, Joseph A. DiGiuseppe, Lata Mukundan, John Milburn Jessup, Brent L. Wood, Bruce Greig, Elisabeth Paietta, Gary J. Kelloff, Howard R. Higley, Michael Keeney, Caroline C. Sigman, Benjamin D. Hedley
Publikováno v:
Blood. 128:2907-2907
Background: Minimal residual disease (MRD) in B lymphoblastic leukemia (B-ALL) as measured by flow cytometry is well-established as an important prognostic factor; Its presence is used to adjust treatment in most therapeutic protocols in children , w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f1d6dada22609b3897a77f0fe062512
https://doi.org/10.1182/blood.v128.22.2907.2907
https://doi.org/10.1182/blood.v128.22.2907.2907
Autor:
Andrew K. Stewart, John Milburn Jessup, Leonard L. Gunderson, Daniel J. Sargent, Frederick L. Greene
Purpose The sixth edition of American Joint Committee on Cancer (AJCC) Cancer Staging Manual for colon cancer subdivided stage II into IIA (T3N0) and IIB (T4N0) and stage III into IIIA (T1-2N1M0), IIIB (T3-4N1M0), and IIIC (anyTN2M0). Subsequent anal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::409df384990a71b9959a3f2ae92d0c3e
https://europepmc.org/articles/PMC2815715/
https://europepmc.org/articles/PMC2815715/
Publikováno v:
Molecular Therapy. 23:S46
RNAi combined with oncolytic viral vector therapy may provide a new approach to control malignant disease since allele specific shRNA to a retrogene that modulates stemness will inhibit growth of human CRC in vivo. Our original delivery vector was no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbb726b20601e611c247a145ba4d254f
https://doi.org/10.1016/s1525-0016(16)33714-5
https://doi.org/10.1016/s1525-0016(16)33714-5
Autor:
Jeffrey I. Kreisberg, James W. Freeman, Shazli Malik, Daniel T. DeArmond, Shujie Zhao, John Milburn Jessup, Michael G. Brattain
Publikováno v:
Oncogene. 22(49)
Pancreatic ductal adenocarcinoma (PDAC) cell lines, MIA PaCa-2, and UK Pan-1, were used to investigate the role of ErbB2 in PDAC oncogenesis. Both these cell lines exhibit exogenous growth factor-independent proliferation that was attributed to the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fef104c265cab984b638f794bd0950e0
https://pubmed.ncbi.nlm.nih.gov/14586404
https://pubmed.ncbi.nlm.nih.gov/14586404
Autor:
Andrew K. Stewart, Leonard L. Gunderson, John Milburn Jessup, Daniel J. Sargent, Frederick L. Greene
Publikováno v:
Journal of Clinical Oncology. 26:4020-4020
4020 Background: The 6th edition (ed) of AJCC staging subdivided Stage II into IIA(T3N0)/IIB(T4N0) and Stage III into IIIA(T1–2N1M0), IIIB(T3–4N1M0), IIIC(anyTN2M0). Subsequent analyses supported f...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bece332c2f92433db9d99b8bdf3f821
https://doi.org/10.1200/jco.2008.26.15_suppl.4020
https://doi.org/10.1200/jco.2008.26.15_suppl.4020